ARTICLE | Company News
Lysosomal, Allergan deal
January 12, 2017 10:17 PM UTC
Allergan purchased from Lysosomal an exclusive option to acquire the company following completion of a Phase Ib trial of LTI-291. The preclinical candidate is designed to simulate activity of glucocer...